Bd announces cfo transition plan

Provides preliminary revenue for fourth quarter and full year fiscal 2025  franklin lakes, n.j. , oct. 15, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, announced today a transition plan under which chris delorefice, executive vice president and chief financial officer (cfo), will depart the company effective dec. 5, 2025, to pursue a new professional opportunity.
BDX Ratings Summary
BDX Quant Ranking